Management of non-small-cell lung cancer in the older adult

Maturitas

Volumn 68, Issue 4, 2011, Pages 311-321

  Vanderwalde, Ari ^a   Pal, Sumanta Kumar ^a   Reckamp, Karen L ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Combination chemotherapy; Geriatric assessment; Geriatric oncology; Lung cancer; Supportive care; Targeted therapeutics

Indexed keywords

ACETYLSALICYLIC ACID; AMINOGLYCOSIDE; AMPHOTERICIN; BEVACIZUMAB; CARBOPLATIN; CETUXIMAB; CISPLATIN; CYCLOSPORIN; DOCETAXEL; ERLOTINIB; ERYTHROMYCIN; ETOPOSIDE; FUROSEMIDE; GEFITINIB; GEMCITABINE; IRINOTECAN; KETOCONAZOLE; NAVELBINE; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; PEMETREXED; PHENYTOIN; WARFARIN;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ADVANCED CANCER; AGE; AGING; ALOPECIA; ANEMIA; ANOREXIA; ASTHENIA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; COGNITION; COMORBIDITY; CONSTIPATION; DIARRHEA; DISEASE FREE SURVIVAL; DRUG EXCRETION; DRUG FEVER; DRUG HYPERSENSITIVITY; EDEMA; EOSINOPHILIC ESOPHAGITIS; ESOPHAGITIS; FATIGUE; FLU LIKE SYNDROME; GERIATRIC CARE; HAND FOOT SYNDROME; HUMAN; HYPERTENSION; LEUKOPENIA; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MACULOPAPULAR RASH; METASTASIS; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; NUTRITIONAL STATUS; OTOTOXICITY; PALLIATIVE THERAPY; PERIPHERAL NEUROPATHY; PLEURA EFFUSION; PNEUMONIA; PROGRESSION FREE SURVIVAL; PROTEINURIA; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; RASH; REVIEW; SIDE EFFECT; SOCIAL SUPPORT; THROMBOCYTOPENIA; THROMBOEMBOLISM; VOMITING; WEIGHT GAIN;

AGE FACTORS; AGED; CARCINOMA, NON-SMALL-CELL LUNG; GERIATRIC ASSESSMENT; HUMANS; LUNG NEOPLASMS; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 79953057029     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2011.01.008     Document Type: Review

References (91)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 2010 June 17 [Epub ahead of print]
2. S. Altekruse, C. Kosary, and M. Krapcho SEER cancer statistics review, 1975-2007 2010 National Cancer Institute Bethesda, MD based on November 2009 SEER data submission, posted to the SEER web site http://seer.cancer.gov/csr/ 1975-2007/
3. E.M. Blanchard, K. Arnaoutakis, and P.J. Hesketh Lung cancer in octogenarians J Thorac Oncol 5 6 2010 909 916
4. L.F. Hutchins, J.M. Unger, J.J. Crowley, C.A. Coltman, and K.S. Albain Under representation of patients 65 years of age or older in cancer-treatment trials N Engl J Med 341 1999 2061 2067 (Pubitemid 30035956)
5. L. Talarico, G. Chen, and R. Pazdur Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration J Clin Oncol 22 2004 4626 4631 (Pubitemid 41185131)
6. K.W. Yee, J.L. Pater, L. Pho, B. Zee, and L.L. Siu Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier? J Clin Oncol 21 April (8) 2003 1618 1623 (Pubitemid 46594117)
7. V.H. Murthy, H.M. Krumholz, and C.P. Gross Participation in cancer clinical trials: race-, sex-, and age-based disparities JAMA 291 June (22) 2004 2720 2726 (Pubitemid 38725421)
8. J.H. Stewart, A.G. Bertoni, J.L. Staten, E.A. Levine, and C.P. Gross Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities Ann Surg Oncol 14 December (12) 2007 3328 3334 (Pubitemid 350160101)
9. J.H. Lewis, M.L. Kilgore, and D.P. Goldman Participation of patients 65 years of age or older in cancer clinical trials J Clin Oncol 21 April (7) 2003 1383 1389 (Pubitemid 46606420)
10. J.M. de Rijke, L.J. Schouten, and G.P. ten Velde Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study Lung Cancer 46 November (2) 2004 233 245 (Pubitemid 39334825)
11. S.K. Vinod, M.A. Sidhom, G.S. Gabriel, M.T. Lee, and G.P. Delaney Why do some lung cancer patients receive no anticancer treatment? J Thorac Oncol 5 7 2010 1025 1032
12. J.S. Brown, D. Eraut, C. Trask, and A.G. Davison Age and the treatment of lung cancer Thorax 51 6 1996 564 568 (Pubitemid 26226507)
13. G.R. Oxnard, P. Fidias, A. Muzikansky, and L.V. Sequist Non-small cell lung cancer in octogenarians: treatment practices and preferences J Thorac Oncol 2 11 2007 1029 1035 (Pubitemid 350059579)
14. A.J. Davidoff, M. Tang, B. Seal, and M.J. Edelman Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer J Clin Oncol 28 May (13) 2010 2191 2197
15. J.A. Foster, G.D. Salinas, D. Mansell, J.C. Williamson, and L.L. Casebeer How does older age influence oncologists' cancer management? Oncologist 15 2010 584 592
16. E.A. Quoix, J. Oster, and V. Westeel Weekly paclitaxel combined with monthly carboplatin versus single-agent therapy in patients age 70 to 89: IFCT-0501 randomized phase III study in advanced non-small cell lung cancer (NSCLC) J Clin Oncol 28 2010 18s [suppl.; abstract 2]
17. A.U. Ferrari, A. Radaelli, and M. Centola Invited review: aging and the cardiovascular system J Appl Physiol 95 December (6) 2003 2591 2597 (Pubitemid 37445007)
18. R. Sawhney, M. Sehl, and A. Naeim Physiologic aspects of aging: impact on cancer management and decision making, part I Cancer J 11 November-December (6) 2005 449 460 (Pubitemid 43097072)
19. M. Sehl, R. Sawhney, and A. Naeim Physiologic aspects of aging: impact on cancer management and decision making, part II Cancer J 11 November-December (6) 2005 461 473 (Pubitemid 43097073)
20. L. Repetto, L. Fratino, and R. Audisio Comprehensive geriatric assessment adds information to Eastern Cooperative Group performance status in elderly cancer patients; an Italian Group for Geriatric Oncology Study J Clin Oncol 20 2 2002 494 502 (Pubitemid 34072534)
21. A. Rao, F. Hsieh, J. Feusser, and H. Cohen Geriatric evaluation and management units in the care of the frail elderly patient J Gerontol A Biol Sci Med Sci 60 6 2005 798 803 (Pubitemid 40881190)
22. P. Maione, F. Perrone, and C. Gallo Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the Multicenter Italian Lung Cancer in the elderly study J Clin Oncol 23 October (28) 2005 6865 6872
23. G. Frasci, V. Lorusso, and N. Panza Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer J Clin Oncol 18 13 2000 2529 2536 (Pubitemid 30432518)
24. A. Hurria, S. Gupta, and M. Zauderer Developing a cancer-specific geriatric assessment: a feasibility study Cancer 104 November (9) 2005 1998 2005 (Pubitemid 41513186)
25. G. Freyer, J. Geay, and S. Touzet Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study Ann Oncol 16 11 2005 1795 1800 (Pubitemid 41631242)
26. A. Hurria, K. Togawa, and S.G. Mohile Predicting chemotherapy toxicity in older adults with cancer: a prospective 500 patient multicenter study J Clin Oncol 28 2010 15s [suppl.; abstract 9001]
27. M. Extermann, I. Boler, and R. Reich The chemotherapy risk assessment scale for high-age patients (CRASH) score: design and validation J Clin Oncol 28 2010 15s [suppl.; abstract 9000]
28. M.Y. Chang, S.J. Mentzer, and Y.L. Colson Factors predicting poor survival after resection of stage IA non-small cell lung cancer J Thorac Cardiovasc Surg 134 October (4) 2007 850 856 (Pubitemid 47454622)
29. D.R. Wong, and H.J. Henteleff Ten-year follow-up of a province-wide cohort of surgical lung cancer patients in Nova Scotia Can J Surg 51 August (4) 2008 257 262
30. T.R. Asmis, K. Ding, and L. Seymour Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials J Clin Oncol 26 January (1) 2008 54 59
31. R. Yancik Cancer burden in the aged: an epidemiologic and demographic overview Cancer 80 October (7) 1997 1273 1283 (Pubitemid 27407230)
32. O. Birim, H.M. Zuydendorp, A.P. Maat, A.P. Kappetein, M.J. Eijkemans, and A.J. Bogers Lung resection for non-small-cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population Ann Thorac Surg 76 December (6) 2003 1796 1801 (Pubitemid 37510479)
33. T. Ishida, H. Yokoyama, S. Kaneko, K. Sugio, and K. Sugimachi Long-term results of operation for non-small cell lung cancer in the elderly Ann Thorac Surg 50 December (6) 1990 919 922
34. P. Thomas, M. Piraux, L.F. Jacques, J. Gregoire, P. Bedard, and J. Deslauriers Clinical patterns and trends of outcome of elderly patients with bronchogenic carcinoma Eur J Cardiothorac Surg 13 March (3) 1998 266 274 (Pubitemid 28206902)
35. H. Rostad, A. Naalsund, T.E. Strand, R. Jacobsen, O. Talleraas, and J. Norstein Results of pulmonary resection for lung cancer in Norway, patients older than 70 years Eur J Cardiothorac Surg 27 February (2) 2005 325 328 (Pubitemid 40193145)
36. V. Sullivan, T. Tran, and A. Holmstrom Advanced age does not exclude lobectomy for non-small cell lung carcinoma Chest 128 4 2005 2671 2676 (Pubitemid 41507626)
37. A. Dominguez-Ventura, S.D. Cassivi, and M.S. Allen Lung cancer in octogenarians: factors affecting long-term survival following resection Eur J Cardiothorac Surg 32 2 2007 370 374 (Pubitemid 47021422)
38. S. Bolukbas, S. Beqiri, T. Bergmann, S. Trainer, A. Fisseler-Eckhoff, and J. Schirren Pulmonary resection of non-small cell lung cancer: is survival in the elderly not affected by tumor stage after complete resection? Thorac Cardiovasc Surg 56 December (8) 2008 476 481
39. T. Winton, R. Livingston, and D. Johnson Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 352 June (25) 2005 2589 2597 (Pubitemid 41007845)
40. C. Pepe, B. Hasan, and T.L. Winton Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10 J Clin Oncol 25 April (12) 2007 1553 1561 (Pubitemid 46733082)
41. M. Fruh, E. Rolland, and J.P. Pignon Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer J Clin Oncol 26 July (21) 2008 3573 3581
42. R.O. Dillman, J. Herndon, S.L. Seagren, W.L. Eaton Jr., and M.R. Green Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial J Natl Cancer Inst 88 September (17) 1996 1210 1215 (Pubitemid 26302034)
43. R.O. Dillman, S.L. Seagren, and K.J. Propert A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer N Engl J Med 323 October (14) 1990 940 945 (Pubitemid 20332333)
44. A. Auperin, C. Le Pechoux, and J.P. Pignon Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients Ann Oncol 17 March (3) 2006 473 483 (Pubitemid 43329586)
45. T. Le Chevalier, R. Arriagada, and E. Quoix Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients J Natl Cancer Inst 83 March (6) 1991 417 423
46. C.J. Langer, C. Hsu, and W.J. Curran Elderly patients with locally advanced non-small cell lung cancer benefit from combined modality therapy: secondary analysis of Radiation Therapy Oncology Group (RTOG) 94-10 [abstract 1193] Proc Am Soc Clin Oncol 21 2002
47. G. Clamon, J. Herndon, R. Cooper, A.Y. Chang, J. Rosenman, and M.R. Green Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group J Clin Oncol 17 January (1) 1999 4 11 (Pubitemid 29022371)
48. C.M. Rocha Lima, J.E. Herndon 2nd, M. Kosty, G. Clamon, and M.R. Green Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B Cancer 94 January (1) 2002 181 187 (Pubitemid 34049057)
49. C.G. Giorgio, A. Pappalardo, and A. Russo A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer Anticancer Drugs 18 July (6) 2007 713 719 (Pubitemid 47343666)
50. J.H. Schiller, D. Harrington, and C.P. Belani Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N Engl J Med 346 January (2) 2002 92 98 (Pubitemid 34438899)
51. Elderly Lung Cancer Vinorelbine Italian Study Group Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer J Natl Cancer Inst 91 January (1) 1999 66 72
52. S. Kudoh, K. Takeda, and K. Nakagawa Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904) J Clin Oncol 24 August (22) 2006 3657 3663 (Pubitemid 46630541)
53. S.S. Leong, C.K. Toh, and W.T. Lim A randomized phase II trial of single-agent gemcitabine, vinorelbine, or docetaxel in patients with advanced non-small cell lung cancer who have poor performance status and/or are elderly J Thorac Oncol 2 March (3) 2007 230 236 (Pubitemid 47181328)
54. I.S. Choi, B.S. Kim, and S.R. Park Efficacy of modified regimen with attenuated doses of paclitaxel plus carboplatin combination chemotherapy in elderly and/or weak patients with advanced non-small cell lung cancer Lung Cancer 39 January (1) 2003 99 101 (Pubitemid 36020301)
55. J. Feliu, G. Martin, and C. Madronal Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer Cancer Chemother Pharmacol 52 September (3) 2003 247 252 (Pubitemid 37204539)
56. C.G. Giorgio, A. Pappalardo, and A. Russo A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) Lung Cancer 51 March (3) 2006 357 362 (Pubitemid 43265819)
57. Y. Ohe, S. Niho, and R. Kakinuma A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients Ann Oncol 15 January (1) 2004 45 50 (Pubitemid 38139602)
58. C. Gridelli, F. Perrone, and C. Gallo Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial J Natl Cancer Inst 95 March (5) 2003 362 372 (Pubitemid 36395256)
59. P. Comella, A. Gambardella, G. Frasci, A. Avallone, and R. Costanzo Comparison of the safety and efficacy of paclitaxel plus gemcitabine combination in young and elderly patients with locally advanced or metastatic non-small cell lung cancer. A retrospective analysis of the Southern Italy Cooperative Oncology Group trials Crit Rev Oncol Hematol 65 February (2) 2008 164 171
60. C.J. Langer, J. Manola, and P. Bernardo Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial J Natl Cancer Inst 94 February (3) 2002 173 181 (Pubitemid 34162751)
61. R. Rosell, T. Moran, and C. Queralt Screening for epidermal growth factor receptor mutations in lung cancer N Engl J Med 361 September (10) 2009 958 967
62. G.J. Riely, W. Pao, and D. Pham Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib Clin Cancer Res 12 February (3 Pt 1) 2006 839 844 (Pubitemid 43259866)
63. D.M. Jackman, B.Y. Yeap, and L.V. Sequist Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib Clin Cancer Res 12 July (13) 2006 3908 3914 (Pubitemid 44078074)
64. H. Kimura, K. Kasahara, and M. Kawaishi Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer Clin Cancer Res 12 July (13) 2006 3915 3921 (Pubitemid 44078075)
65. F.A. Shepherd, J. Rodrigues Pereira, and T. Ciuleanu Erlotinib in previously treated non-small-cell lung cancer N Engl J Med 353 July (2) 2005 123 132 (Pubitemid 41058344)
66. D.M. Jackman, B.Y. Yeap, and N.I. Lindeman Phase II clinical trial of chemotherapy-naive patients > or =70 years of age treated with erlotinib for advanced non-small-cell lung cancer J Clin Oncol 25 March (7) 2007 760 766 (Pubitemid 350002874)
67. N. Ebi, H. Semba, and S.J. Tokunaga A phase II trial of gefitinib monotherapy in chemotherapy-naive patients of 75 years or older with advanced non-small cell lung cancer J Thorac Oncol 3 October (10) 2008 1166 1171
68. L. Crino, F. Cappuzzo, and P. Zatloukal Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study J Clin Oncol 26 September (26) 2008 4253 4260
69. Y. Chen, C. Tsai, and J. Shih Phase II randomized trial of erlotinib versus vinorelbine in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) aged ≥70 years in Taiwan [abstract 8051] J Clin Oncol 27 2009 15s (suppl.)
70. R. Pirker, J.R. Pereira, and A. Szczesna Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial Lancet 373 May (9674) 2009 1525 1531
71. A. Sandler, R. Gray, and M.C. Perry Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer N Engl J Med 355 December (24) 2006 2542 2550 (Pubitemid 44917502)
72. M. Reck, J. von Pawel, and P. Zatloukal Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil J Clin Oncol 27 March (8) 2009 1227 1234
73. S.S. Ramalingam, S.E. Dahlberg, and C.J. Langer Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599 J Clin Oncol 26 January (1) 2008 60 65
74. N.B. Leighl, P. Zatloukal, and J. Mezger Efficacy and safety of bevacizumab-based therapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer in the phase III BO17704 study (AVAiL) J Thorac Oncol 5 December (12) 2010 1970 1976
75. F.A. Scappaticci, J.R. Skillings, and S.N. Holden Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab J Natl Cancer Inst 99 August (16) 2007 1232 1239 (Pubitemid 47299901)
76. NCCN Clinical Practice Guidelines in Oncology Non-small cell lung cancer, V.2.2011 2010 [accessed 12.23.10]. http://www.nccn.org/professionals/physician- gls/PDF/nscl.pdf
77. S.J. Gauden, and L. Tripcony The curative treatment by radiation therapy alone of Stage I non-small cell lung cancer in a geriatric population Lung Cancer 32 April (1) 2001 71 79 (Pubitemid 32224841)
78. D. Palma, O. Visser, F.J. Lagerwaard, J. Belderbos, B.J. Slotman, and S. Senan Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis J Clin Oncol 28 December (35) 2010 5153 5159
79. S. Pergolizzi, A. Santacaterina, and C.D. Renzis Older people with non small cell lung cancer in clinical stage IIIA and co-morbid conditions. Is curative irradiation feasible? Final results of a prospective study Lung Cancer 37 August (2) 2002 201 206 (Pubitemid 34835689)
80. L. Balducci, H. Al-Halawani, and V. Charu Elderly cancer patients receiving chemotherapy benefit from first-cycle pegfilgrastim Oncologist 12 December (12) 2007 1416 1424
81. A.G. Pallis, C. Fortpied, and U. Wedding EORTC elderly task force position paper: approach to the older cancer patient Eur J Cancer 46 June (9) 2010 1502 1513
82. J.D. Rizzo, A.E. Lichtin, and S.H. Woolf Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology J Clin Oncol 20 October (19) 2002 4083 4107
83. C. Bokemeyer, M.S. Aapro, and A. Courdi EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update Eur J Cancer 43 January (2) 2007 258 270 (Pubitemid 46127840)
84. J. Bohlius, K. Schmidlin, and C. Brillant Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials Lancet 373 May (9674) 2009 1532 1542
85. J. Bohlius, K. Schmidlin, and C. Brillant Erythropoietin or darbepoetin for patients with cancer - meta-analysis based on individual patient data Cochrane Database Syst Rev 8 3 2009 CD007303
86. 3-receptor antagonists in the first 24 hours Gerontology 51 2005 287 296 (Pubitemid 41191598)
87. C. Gridelli Same old story? Do we need to modify our supportive care treatment of elderly cancer patients? Focus on antiemetics Drugs Aging 21 13 2004 825 832 (Pubitemid 39487068)
88. NCCN Clinical Practice Guidelines in Oncology Antiemesis, V.1.2011 2010 [accessed 12.21.10] http://www.nccn.org/professionals/physician-gls/PDF/ antiemesis.pdf
89. S.D. Baker, and L.B. Grochow Pharmacology of cancer chemotherapy in the older person Clin Geriatr Med 13 February (1) 1997 169 183 (Pubitemid 27084049)
90. G. Sharma, J. Freeman, D. Zhang, and J.S. Goodwin Trends in end-of-life ICU use among older adults with advanced lung cancer Chest 133 January (1) 2008 72 78
91. C.G. Azzoli, S. Baker Jr., and S. Temin American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer J Clin Oncol 27 December (36) 2009 6251 6266